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The selective immobilization of proteins represents an essential step in the
selection of binding proteins such as antibodies. The immobilization strategy
determines how the target protein is presented to the binders and thereby
directly affects the experimental outcome. This poses specific challenges for
membrane proteins due to their inherent lack of stability and limited exposed
hydrophilic surfaces. Here we detail methodologies for the selective
immobilization of membrane proteins based on the strong biotin-avidin
interaction and with a specific focus on its application for the selection of
nanobodies and sybodies. We discuss the challenges in generating and benefits
of obtaining an equimolar biotin to target-protein ratio.
Biotinylation of Membrane Proteins for Binder Selections | SpringerLink https://link.springer.com/protocol/10.1007/978-1-0716-0373-4_11#enum...
1 von 26 19.01.2021, 15:36
Biotin Neutravidin Streptavidin FX cloning Avi-tag Panning 
Phage display Ribosome display Nanobodies Sybodies 
Antibody fragments and in particular nanobodies have become indispensable
tools for studying structural and functional aspects of membrane proteins [ ].
The generation of these binders involves the stringent phenotypic selection of
individual members from libraries holding many variants. Central to this
procedure is the selective immobilization of the target protein to enrich those
members of the library that specifically interact with it. We recently developed
an in vitro selection platform based on three large synthetic nanobody (sybody)
libraries that allows the generation of binders under entirely defined and mild
conditions compatible with membrane proteins [ ]. A major hallmark of our
platform is its optimization toward the routine selection of binders against
membrane proteins, which entails successive alterations in display technology,
immobilization surface, and the application of solution panning. The latter
allows the free target protein to interact with the displayed binders in solution,
preceding a rapid (within minutes) immobilization on beads and subsequent
pull-down of the target protein-binder complexes. Hereby delicate membrane
proteins are protected from denaturation resulting from prolonged exposure to
surfaces at high protein densities. Hence, the selective immobilization of the
target protein is a key step in selection procedures.
Though seemingly trivial, the choice of the immobilization strategy is of great
relevance as this may dramatically skew the selection and directly affect the
quality and quantity of unique binders identified. Given the aim of obtaining
multiple strong binders against different, three-dimensional epitopes, an ideal
protein immobilization strategy should: (1) preserve the native three-
dimensional structure; (2) allow a non-oriented, ideally random orientation of
the target protein with high accessibility of potential epitopes; (3) capture the
target protein selectively, rapidly (within a few minutes), and stably (over
prolonged periods of several hours) in a variety of buffer conditions and a
broad temperature range; and (4) allow near-complete capture of the target
protein to avoid loss of binder diversity during solution panning. In addition,
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the strategy should not interfere with biogenesis and function of the target
protein and should be facile to implement. Among the multitude of protein
immobilization strategies [ ], the biotin/avidin-based interaction fits these
criteria best and is therefore widely used [ ].
The interaction between the vitamin biotin and avidin or its variants
streptavidin and neutravidin is one of the strongest non-covalent interactions
known (K  of ~10  M) and has a half-life of several days [ , ]. The
interaction remains stable over a broad range of temperatures [ ], pH values,
and denaturants [ , ]. Avidin, streptavidin, and neutravidin are
homotetrameric proteins with four biotin-binding sites. Streptavidin, derived
from bacterial origin, and neutravidin, a deglycosylated form of avidin, are
generally preferred over avidin, as the absence of glycosylation and their lower
pI values reduce nonspecific binding [ , ]. Importantly, naturally biotinylated
proteins are rare: in E. coli or mammalian cells the number of proteins holding
a covalently attached biotin amount to one and four, respectively [ , ].
Biotinylation of a target membrane protein can be achieved chemically or
enzymatically. Chemical biotinylation is most conveniently done by targeting
the primary amine of a surface-exposed lysine residue using biotin derivatized
with an N-hydroxysuccinimide (NHS) group. This reaction can be performed
under comparably mild, biocompatible conditions. Due to the general
abundance of lysines on protein surfaces, amine chemistry allows the
introduction of biotin at different positions in the protein. Consequently, the
target protein can be immobilized in several orientations allowing exposure of
different potential epitopes, provided that only one biotin group is introduced.
A higher degree of labeling is disadvantageous as this may restrict flexibility
and surface presentation and may even directly interfere with binding of the
antibody by masking the epitope. As an alternative to the comparably
abundant lysines, cysteines may be targeted using, e.g., biotin derivatized with
a maleimide group. The main advantage of chemical biotinylation is the
random target orientation during immobilization. This comes at the price of
two disadvantages: chemical biotinylation typically results in a distribution of
target proteins carrying none, one, or multiple biotin moieties; and
biotinylation of lysines may modify, and thereby mask, potential epitopes.
The E. coli biotin protein ligase BirA requires biotin and ATP to biotinylate its
only target, the biotin carboxyl carrier protein (BCCP) subunit of acetyl-CoA
carboxylase, at a specific lysine in an evolutionary conserved amino acid
sequence. Engineering of this sequence led to the identification of the Avi-tag,
a 15 amino acid stretch, GLNDIFEAQ-K-IEWHE, that is biotinylated with high
efficiency [ , ]. Avi-tags fused to the N- or C-terminus [ ] or even
integrated in exposed loops [ ] are efficiently biotinylated by BirA. Enzymatic
biotinylation of membrane proteins can be done in vivo using native or co-
expressed BirA or in vitro using the purified BirA protein. The main advantage
of enzymatic biotinylation is its high efficiency and specificity, resulting in
nearly complete and exclusive biotinylation of the lysin residue in the Avi-tag.
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Hence, the highly desirable biotin to target protein ratio of 1:1 can easily be
achieved. However, enzymatic biotinylation has two major disadvantages: all
target proteins are immobilized in the same orientation, which may render
some epitopes inaccessible; this problem is exacerbated for homo-oligomeric
target proteins, where several biotin moieties are introduced via the Avi-tag;
and the attachment of the Avi-tag sequence to the open reading frame of the
target protein requires molecular cloning and potentially construct
optimization.
The biochemical quality of the membrane protein target is arguably the most
critical parameter when performing binder selections. Hence, it is paramount
that the biotinylation procedure does not compromise the structure and
function of the target protein. Therefore, biotinylated target proteins need to
be experimentally tested for activity and structural integrity using size
exclusion chromatography, both for enzymatic and chemical biotinylation.
This chapter first details a facile cloning strategy for fusing sequences for N- or
C-terminal Avi-tags to the target open reading frame. Subsequently, we
describe approaches for enzymatic and chemical biotinylation of (Avi-tagged)
membrane proteins and conclude with methodology to assess the degree of
biotinylation. Together, this chapter provides all relevant information required
to selectively immobilize membrane proteins using the biotin/avidin
interaction.
FX Cloning
FX cloning vectors. E. coli expression vectors for the arabinose-
controlled P  promoter [ ] and holding sequences coding for
an Avi-tag in combination with an HRV 3C protease cleavable
GFP-His-tag or His-tag (Fig. ) are available on Addgene (#47069,
#47071-47075). The optional intermediate vector pINIT_cat for
subcloning is available on Addgene as well (#46858). All FX
cloning vectors should be propagated in a CcdB-resistant E. coli
strain such as DB3.1 [ ].
Dedicated forward and reverse primers targeting the gene of
interest and compatible with FX cloning. For ordering, choose the
smallest synthesis scale and mere desalting as purification.
Template DNA for the open reading frame of interest (e.g.,
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genomic DNA or plasmid).
Phusion DNA polymerase, corresponding buffer, and dNTPs.
TAE buffer, TAE agarose gel, and agarose gel DNA extraction kit.
SapI restriction enzyme and corresponding buffer.
T4 DNA ligase.
10 mM ATP: 10 mM Na -ATP, 10 mM MgSO . Dissolve in 50 mM
KPi, pH 7.0 and adjust to pH 6.5–7.0 with NaOH. Store in small
aliquots at −20 °C.
CcdB-sensitive E. coli strain (e.g., MC1061 [ ]).
LB medium and LB-agar plate supplemented with the appropriate
antibiotic. For ampicillin (Amp) and chloramphenicol (Cam), use
100 μg/mL and 34 μg/mL, respectively.
Miniprep kit (QIAGEN).
Sequencing primers for pINIT_cat or the arabinose-controlled
P  expression vectors (Table ).
2 4
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BirA-Based In Vitro Biotinylation
BirA at 8 mg/mL (228 μM) in 50 mM Tris–HCl pH 7.5, 200 mM
KCl, 50% glycerol, 0.1 mM DTT. His-tagged BirA can be produced
using pET21a-BirA (Addgene) as described [ ] but it is also
commercially available (e.g., from Sigma-Aldrich). Store for
prolonged periods at −80 °C. Substocks stored at −20 °C will
remain liquid and ready to use.
HRV 3C protease at 6 mg/mL (276 μM) in 50 mM Tris–HCl
pH 7.5, 150 mM NaCl, 1 mM TCEP, and 50% glycerol. His-tagged
3C protease can be produced as described [ ] but is also
commercially available (e.g., from Sigma-Aldrich). Store 100 μL
aliquots at −80 °C.
200 mM ATP (dissolve in 50 mM KPi, pH 7.0 and adjust to
pH 6.5–7.0 with NaOH).
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1 mM biotin in 50 mM Bicine buffer pH 8.3. Store in small aliquots
at −20 °C.
1 M MgOAc.
Ni-NTA resin or prepacked Ni-NTA column.
BirA-Based In Vivo Biotinylation
Expression vectors. Mammalian vectors for protein expression
based on a pCDNA3.1(+) backbone (Thermo Fisher) controlled by
a CMV promoter and holding a Kozak sequence preceding
sequence coding for an N- (pC039) or C-terminal (pC031) Avi-tag
in combination with an HRV 3C protease cleavable GFP-His-tag,
respectively (Fig. ).
BirA co-expression vectors. Co-expression of E. coli BirA in
mammalian cell culture and under control of a CMV promoter is
assured by the presence of an additional plasmid coding for BirA
with a C-terminal Myc-tag for intracellular biotinylation, or BirA
with an N-terminal IgH signal sequence and C-terminal KDEL ER-
retention signal for biotinylation of extracellularly located Avi-tags.
Opti-MEM reduced serum medium (Thermo Fisher).
ExpiFectamine 293 transfection kit (Thermo Fisher; part of the
expression kit).
Expi293 expression medium (Thermo Fisher) and Freestyle
medium (Thermo Fisher).
Fernbach cell culture shaking flask (e.g., 3 L) plus CO -gassed
shaker platform.
Optional: 2.1 mM biotin in Expi293 medium.
Steritop filter (250 mL, Millipore).
Chemical Biotinylation
PBS buffer pH 7.4, 137 mM NaCl, 2.7 mM KCl, 10 mM Na HPO ,
1.8 mM KH PO .




Biotinylation of Membrane Proteins for Binder Selections | SpringerLink https://link.springer.com/protocol/10.1007/978-1-0716-0373-4_11#enum...











Assessing Degree of Biotinylation
Streptavidin at 1 mg/mL in MilliQ. Store in aliquots at −20 °C.
5× SDS-PAGE sample buffer.
SDS-PAGE gel and setup.
FX Cloning
Design FX-cloning compatible primers targeting your gene of
interest. This is most conveniently done online at the
https://www.fxcloning.org  (https://www.fxcloning.org) website
using a FASTA-formatted sequence including a start and stop
codon. Order the primer set optimized toward removal of stable
hairpin structures (see No te ).
Amplify the gene of interest by PCR. Prepare a 50 μL PCR reaction
and add the DNA polymerase immediately prior to starting the
reaction. Use a touch-down [ ] program, e.g., (1) 30 s at 98 °C;
(2) 10 s at 98 °C; (3) 15 s at 61 °C (annealing temperature
decreased by 0.5 °C per cycle); (4) 15–30 s/kb at 72 °C; repeat
(2)–(4) 14 times; (5) 10 s at 98 °C; (6) 15 s at 53 °C; (7) 15–30 s/kb
at 72 °C; repeat (5)–(7) 14 times; (8) 120 s at 72 °C; (9) unlimited
at 10 °C.
Analyze the product on a preparative TAE agarose gel. Purify the
relevant band using a DNA gel extraction kit and quantify the DNA
spectrophotometrically.
Mix 50 ng of pINIT_cat with the extracted insert in a molar ratio of
vector:insert of 1:5 (see No te ).
Add 1 μL 10× SapI buffer and adjust the volume to 9 μL with
ultrapure water. Add 1 μL SapI (2 U) and incubate for 1 h at 37 °C
in a PCR machine.
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Heat inactivate the SapI for 20 min at 65 °C. Let the sample cool
down and add 1.25 μL 10 mM ATP and 1.25 μL T4 DNA ligase
(1.25 U). Incubate for 1 h at room temperature.
Heat inactivate the T4 DNA ligase for 20 min at 65 °C and
transform 5 μL of the ligation mix to 100 μL chemically competent
E. coli MC1061 cells (or an alternative CcdB-sensitive strain).
Plate 10% and 90% aliquots on LB-agar-Cam plates and incubate
overnight at 37 °C.
Use a single colony to inoculate 5 mL LB-Cam and cultivate
overnight. Isolate the plasmid using a miniprep kit, determine the
concentration spectrophotometrically, and verify the insert by
DNA sequencing using the pINIT_cat sequencing primers.
Mix 50 ng of the FX cloning Avi-tag expression vector (see No te )
with pINIT_cat carrying the insert to a molar ratio of
vector:pINIT_cat-derivative of 1:5. Add 1 μL 10× SapI buffer and
adjust the volume to 9 μL with ultrapure water. Add 1 μL SapI
(2 U) and incubate for 1 h at 37 °C in a PCR machine.
Heat inactivate the SapI for 20 min at 65 °C. Let the sample cool
down and add 1.25 μL 10 mM ATP and 1.25 μL T4 DNA ligase
(1.25 U). Incubate for 1 h at room temperature.
Heat inactivate the T4 DNA ligase for 20 min at 65 °C and
transform 5 μL of the ligation mix to 100 μL chemically competent
E. coli MC1061 cells.
Plate 10% and 90% aliquots on LB-agar-Amp plates. Incubate the
plates overnight at 37 °C.
Use a single colony to inoculate 5 mL LB-Amp and cultivate
overnight at 37 °C.
Archive the culture as a glycerol stock at −80 °C (see No te ). This
stock can serve for inoculation of expression cultures based on the
araBAD promoter (see No te s  and ).
BirA-Based In Vitro Biotinylation
Recombinantly express the target protein using previously
established procedures [ ] (see No te ). Purify the Avi-tagged
target protein (see No te ) and determine the protein
concentration spectrophotometrically.
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Add 3C protease to a molar ratio of 1:10 to cleave off the decaHis-
tag while dialyzing the sample for 1 h at 4 °C to remove excess
imidazole (see No te ).
Adjust the target protein concentration to 10–50 μM (either by
dilution or using a concentrator unit). Add biotin to a molar ratio
of target protein:biotin of 1:1.5, 5 mM ATP, 10 mM MgOAc and
BirA to a molar ratio of target protein:BirA of 20:1 (see No te ).
Incubate the sample overnight at 4 °C (see No te ).
Remove His-tagged BirA, HRV 3C protease, and potential
remaining contaminants from the sample by reverse IMAC and
collect the flow-through holding the biotinylated target protein.
Perform size exclusion chromatography (SEC) to remove soluble
aggregates and excess of biotin from the sample (see No te  12 ).
Determine the degree of biotinylation as outlined in Subheading
.
Proceed with the selection of binders such as nanobodies and
sybodies (see No te ) or store the target protein (see No te s
and ).
BirA-Based In Vivo Biotinylation
Generate mammalian expression vectors for the gene of interest in
pC031 or pC039 to obtain a fusion protein with an N- or
C-terminal Avi-tag (see No te s  and ).
Split an Expi293 subculture (see No te ), typically grown to
3-5 × 10  cells/mL, into a 3 L Fernbach shaking flask and adjust to
a final volume of 0.6 L Expi293 medium with a density of 0.7 × 10
cells/mL.
Incubate the culture for 72 h at 37 °C, under humidified
atmosphere and 5% CO  in a shaking incubator.
On the day of the transient transfection, adjust the culture to
830 mL with a density of 3.4 × 10  cells/mL by adding Expi293
medium and/or removing cells.
Add 20 mL biotin solution (final concentration of 50 μM) (see
No te ).
Pipet 50 mL Opti-MEM into a 100 mL sterile Schott bottle. Add
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incubate for 5 min at room temperature.
Pipet 50 mL Opti-MEM into a second 100 mL Schott bottle and
add the two plasmid batches in a final amount of 1 mg to 0.1 mg,
target protein expression plasmid:BirA expression plasmid,
respectively. Shake gently and incubate for 5 min at room
temperature.
Mix the contents of both bottles, filter sterilize, and incubate for
20–30 min at room temperature to form the transfection complex.
Add 100 mL of the formed transfection complex to the Fernbach
shaking flask with 850 mL of cell culture for a final volume of
950 mL. Incubate further at 37 °C and 5% CO  with mild shaking.
Add sterile 5 mL Enhancer 1 and 50 mL Enhancer 2 from the
ExpiFectamine 293 transfection kit at 16–20 h post-transfection
and continue incubation.
Incubate for a total time of approximately 48-72 h post-
transfection depending on the most optimal condition for protein
expression. Harvest the cells by centrifugation at 3000 × g  for
15 min, flash freeze the pellet in liquid nitrogen, and store at
−80 °C.
Purify the biotinylated Avi-tagged target protein (see No te ) and
determine the protein concentration spectrophotometrically.
Determine the degree of biotinylation as outlined in Subheading
. Proceed with the selection of binders such as nanobodies and
sybodies (see No te ) or store the target protein (see No te s
and ).
Chemical Biotinylation
Recombinantly express the target protein using previously
established procedures [ ]. Purify the target protein and employ
preparative SEC using PBS, supplemented with the required
detergent, as buffer (see No te ). Determine the protein
concentration spectrophotometrically.
Concentrate the target protein to 50-200 μM.
Dissolve EZ-Link Sulfo-NHS-LC-Biotin in highly pure DMSO to a
concentration of 10 mM (see No te ).
Add EZ-Link Sulfo-NHS-LC-Biotin to the target protein in fivefold
molar excess and incubate at 25 °C for 30 min under gentle
2
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agitation (see No te ).
Perform SEC to remove excess of biotin from the sample (see No te
).
Determine the biotinylation pattern of the biotinylated target
protein by mass-spectrometry (Fig. , see No te ). In case mass
spectrometry analysis is not available or cannot be carried out due
to the target’s high molecular weight, determine the degree of
biotinylation as outlined in Subheading .
Proceed with the selection of binders such as nanobodies and
sybodies (see No te ) or store the target protein (see No te s
and ).
Assessing Degree of Biotinylation
Mix two aliquots of 10 μg biotinylated target protein with 5× SDS-
PAGE sample buffer.
Add streptavidin to one of the aliquots in a 1:1 molar ratio of target
protein:streptavidin (see No te ).
Analyze the control (no addition) and test (streptavidin addition)
samples in adjacent lanes on SDS-PAGE.
Stain the gel with Coomassie Brilliant Blue R-250 and quantify the
band intensities with the ImageJ software and calculate the degree
of biotinylation (see No te s  and ).
As the N- and C-termini of most proteins are comparably long and
flexible, we generally do not insert a linker sequence between the
target protein and the Avi-tag. Nevertheless, should this be
desired, a sequence for a linker is best introduced at this step.
Alternatively, should subcloning of a sequence-verified open
reading frame not be required, proceed with Ste p 10  and use the
purified PCR product to replace the pINIT_cat holding the insert.
Should an expression and purification strategy for the protein
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already be established, this combination of tags and fusions
proteins should guide the choice for the expression vector. We
recommend the production of protein variants with N- and
C-terminal Avi-tags as this may allow the presentation of different
surfaces of the target protein.
For other expression systems that require fresh transformations
for expression cultures, e.g., those based on the T7 promoter, the
stock serves as a plasmid source. No additional verification by
DNA sequencing is required following the subcloning of a
sequence-verified open reading frame from pINIT_cat to an FX
cloning expression vector.
The FX-cloning expression vectors for fused Avi-tag allow
recombinant expression in E. coli under the control of the P
promotor with decaHis-tag. Instead of subcloning a sequence-
verified ORF from pINITIAL to an FX cloning Avi-tag expression
vector, PCR products can also be cloned immediately into an FX
cloning Avi-tag expression vector. This requires sequence
verification of each expression vector. If multiple expression
vectors are constructed, subcloning from pINITIAL prevents
excessive sequencing. If one aims for only a single Avi-tagged
construct, we recommend starting with pBXNH3CA (Addgene
#47069), which adds a cleavable N-terminal decaHis-tag and a
C-terminal Avi-tag to the protein. In our hands, this vector resulted
in good expression levels for a number of ABC transporters as well
as maltose-binding protein (MBP) and GFP.
Should expression in alternative pro- or eukaryotic systems be
preferred, the P -based expression vectors may serve as facile
intermediates for fusing the Avi-tag sequences.
If the Avi-tagged target protein is expressed in E. coli and if the
Avi-tag sequence is located in the cytoplasm, the Avi-tag will be
biotinylated in vivo by virtue of the natively expressed BirA. The
degree of biotinylation varies from case to case (subject to
availability of biotin, level of target protein overexpression and
accessibility of Avi-tag), but is often incomplete. The degree of in
vivo biotinylation may be increased by co-expression of BirA and
supplementation of the medium with biotin [ ]. However, due to
the relevance of complete biotinylation of the Avi-tag, our protocol
ignores in vivo biotinylation of the target within E. coli and assures
full biotinylation by performing an additional in vitro step. If
required, the degree of native biotinylation can be assessed as
outlined in Subheading .
The BirA-based biotinylation protocol describes the procedure for
His-tagged target protein but can in principle be adapted to
protocols involving other affinity-tags. The use of strep-tags [ ]
BAD
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or fusions with streptavidin-binding-protein (SBP) [ ] should be
avoided as biotinylation of Avi-tags by endogenous BirA, which
may reach a very high degree depending on the experimental
conditions and target protein, will prevent elution from the
respective columns.
Although BirA is inhibited by NaCl (over 100 mM) and glycerol
(over 1%) [ ], we generally use buffers containing 150 mM NaCl
and 10% glycerol if the target membrane protein requires this for
maintaining a well-folded state. We compensate for the reduced
BirA activity by biotinylating for prolonged periods (overnight).
Addition of extra amount of detergent might be necessary to keep
the detergent concentration well above the CMC.
The BirA-based biotinylation reaction can also be performed for 1 h
at room temperature if the target protein is stable under these
conditions. For most membrane proteins we recommend keeping
the sample at 4 °C.
Removal of free biotin is often crucial for downstream processes.
In case no size exclusion chromatography is performed, use
dialysis or a desalting column to remove the excess biotin from the
sample.
The outcome of the binder selection depends to a very large extent
on the quality of the target protein used. Productive binder
selections are expected if: (1) the SEC profile of the biotinylated
target protein is monodisperse and very similar to that obtained
for non-biotinylated target protein; (2) the fraction of non-
biotinylated target protein is less than 10%; and (3) in case of
chemical biotinylation: over-biotinylation is excluded, ideally as
assessed by mass spectrometry.
If possible, the biotinylated target protein is supplemented with
10% glycerol, aliquoted, snap-frozen in liquid nitrogen, and stored
at −80 °C. To assess if freezing is tolerated by the target protein,
compare a frozen/thawed and untreated sample by SEC. If no
discernible aggregation or protein loss is observed, freezing can be
considered as tolerated.
We routinely freeze biotinylated membrane proteins for storage
purposes. Having thus far analyzed more than a dozen membrane
proteins in this manner, we never experienced aggregation
problems due to freezing. Frozen biotinylated proteins remain
stable at −80 °C for several years.
The preferred location of the Avi tag on the target protein depends
on the quality and quantity of the fusion protein that can be
obtained. Both parameters are most easily assessed by using
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fluorescence-detection size-exclusion chromatography (FSEC)
analysis [ ].
Biotinylation of Avi-tags during cultivation can be achieved in
several additional expression systems [ , , ]. These
procedures also require the co-expression of BirA and growth
medium supplemented with biotin.
Numerous expression screenings provided the tendency that
Expi293 is more successful for expressing membrane proteins. As
an alternative we recommend Freestyle 293-F cells.
Implementation of the latter will require small adaptations of the
described workflow for which we refer to the instructions from the
supplier.
Supplementing the medium with biotin is optional. Over the
course of many years and targets we observed virtually complete
biotinylation even in the absence of supplemented biotin.
It is very important that compounds containing primary amines
are absent from the purified protein sample for chemical
biotinylation. A frequent source of primary amines stems from
Tris-buffers. IMAC-purified protein is not pure enough regarding
biogenic amines to be used for NHS coupling.
The NHS moiety of EZ-Link Sulfo-NHS-LC-Biotin reacts with
water and is thereby inactivated. We therefore highly recommend
preparing the Sulfo-NHS-LC-Biotin solution freshly. Keep solid
EZ-Link Sulfo-NHS-LC-Biotin under argon at −80 °C for
prolonged storage.
In case the target protein is unstable at 25 °C, the biotinylation
reaction can be carried out at 4 °C. In this case, increase the biotin-
target protein ratio to 10:1 and incubate for 60 min instead of
30 min.
A typical pattern contains different species containing either none,
one, or several biotin moieties per target protein (Fig. ). Ideally,
the non-biotinylated species should not exceed 10% of the total
species (in the example of GFP labeling shown in Fig. , non-
biotinylated target accounts for around 5%). In case of over- or
under-biotinylation, the biotin-target protein ratio needs to be
adjusted accordingly, while keeping the target protein
concentration and incubation time constant.
The biotinylation of target protein can be quantified by mobility
shift in SDS-PAGE upon addition of streptavidin to the sample.
Streptavidin remains folded and bound to the biotinylated target
protein under conventional SDS-PAGE conditions [ ]. Membrane
protein samples are usually not boiled before SDS-PAGE.
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However, when boiling the sample is required add streptavidin
afterward.
Due to the tetrameric architecture of streptavidin with four biotin-
binding sites, multiple protein bands may be observed, e.g., (1) free
streptavidin (53 kDa), (2) streptavidin associated with a single
target protein, and (3) streptavidin associated with multiple (up to
four) target proteins. In our hands, it is more straightforward to
use the intensity loss of the target protein band upon streptavidin
addition relative to the control sample for quantification. For more
precise quantification we recommend mass spectrometry to
analyze the degree of biotinylation. For qualitative analysis of
target protein biotinylation, western blotting using a streptavidin-
HRP conjugate can be employed.
Incomplete biotinylation might be advantageous regarding
oligomeric proteins. Similar to the presence of multiple biotin
labels on monomeric proteins, the occurrence of multiple biotin
groups per oligomeric protein complex may restrict its flexibility
upon immobilization and thereby decrease the variation and
amount of protein surface accessible to the binders. We
recommend a pull-down of biotinylated target protein with
immobilized streptavidin and compare the pull-down efficiency
with the mobility shift in SDS-PAGE to quantify the biotinylation
per oligomeric unit.
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